TABLE 1

Conditions for receptor binding assays

ReceptorPreparation[3H] LigandDisplacerIncubation Temperature and TimeReferences
(nM)(μM)
Dopamine D2Rat striatum[3H]spiperone (0.5)Spiperone (10)37°C, 10 minHirose et al., 1990
5-HT1ARat hippocampus[3H]8-OH-DPAT (0.15)8-OH-DPAT (1)25°C, 30 minKato et al., 1990
5-HT2ARat cortex[3H]ketanserin (1)Ketanserin (10)37°C, 30 minHirose et al., 1990
5-HT7Human recombinant[3H]5-CT (1)5-HT (1)r.t., 2 hTo et al., 1995
Noradrenaline α1Rat cortex[3H]prazosin (0.5)Prazosin (1)25°C, 30 minKato et al., 1990
Noradrenaline α2AHuman recombinant[3H]MK-912 (0.7)WB4101 (10)27°C, 60 minUhlén et al., 1998
Noradrenaline α2CHuman recombinant[3H]MK-912 (0.2)WB4101 (10)27°C, 60 minUhlén et al., 1998
Histamine H1Guinea pig whole brain[3H]pyrilamine (0.4)Triprolidine (2)25°C, 40 minChang et al., 1979
MuscarinicRat cortex[3H]QNB (0.15)Oxotremorine (100)25°C, 60 minYamamura et al., 1974
  • r.t., room temperature; 5-CT, 5-carboxamidotryptamine; MK-912, (2S,12bS)-1′,3′-dimethylspiro[1,3,4,5′,6,6′,7,12b-octahydro-2H-benzo[b]furo[2,3-a]quinolizine-2,4′-pyrimidin]-2′-one; QNB, quinuclidinyl benzilate.